Severe dermatologic adverse reactions after exposure to lenalidomide in multiple myeloma patients with a positive HLA-DRB1*1501 and HLA-DQB1*0602.

Autor: Penna, Giuseppa1, Allegra, Alessandro1, Romeo, Giuseppa2, Alonci, Andrea1, Cannav, Antonino1, Russo, Sabina1, D'Angelo, Arianna1, Petrungaro, Annamaria1, Musolino, Caterina1
Zdroj: Acta Oncologica. Sep2012, Vol. 51 Issue 7, p944-947. 4p. 2 Charts.
Databáze: Academic Search Ultimate